321 related articles for article (PubMed ID: 17200201)
1. Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling.
Keller CD; Rivera Gil P; Tölle M; van der Giet M; Chun J; Radeke HH; Schäfer-Korting M; Kleuser B
Am J Pathol; 2007 Jan; 170(1):281-92. PubMed ID: 17200201
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulator FTY720 Induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3.
Tölle M; Levkau B; Keul P; Brinkmann V; Giebing G; Schönfelder G; Schäfers M; von Wnuck Lipinski K; Jankowski J; Jankowski V; Chun J; Zidek W; Van der Giet M
Circ Res; 2005 Apr; 96(8):913-20. PubMed ID: 15802614
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling.
Sobel K; Menyhart K; Killer N; Renault B; Bauer Y; Studer R; Steiner B; Bolli MH; Nayler O; Gatfield J
J Biol Chem; 2013 May; 288(21):14839-51. PubMed ID: 23589284
[TBL] [Abstract][Full Text] [Related]
4. The immunomodulator FTY720 and its phosphorylated derivative activate the Smad signalling cascade and upregulate connective tissue growth factor and collagen type IV expression in renal mesangial cells.
Xin C; Ren S; Eberhardt W; Pfeilschifter J; Huwiler A
Br J Pharmacol; 2006 Jan; 147(2):164-74. PubMed ID: 16299553
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of the immunomodulator FTY720 inhibits programmed cell death of fibroblasts via the S1P3 receptor subtype and Bcl-2 activation.
Potteck H; Nieuwenhuis B; Lüth A; van der Giet M; Kleuser B
Cell Physiol Biochem; 2010; 26(1):67-78. PubMed ID: 20502006
[TBL] [Abstract][Full Text] [Related]
6. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP
Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267
[TBL] [Abstract][Full Text] [Related]
7. Smad3 deficiency leads to mandibular condyle degradation via the sphingosine 1-phosphate (S1P)/S1P3 signaling axis.
Mori H; Izawa T; Tanaka E
Am J Pathol; 2015 Oct; 185(10):2742-56. PubMed ID: 26272361
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between PDGF and S1P signalling elucidates the inhibitory effect and potential antifibrotic action of the immunomodulator FTY720 in activated HSC-cultures.
Brunati AM; Tibaldi E; Carraro A; Gringeri E; D'Amico F; Toninello A; Massimino ML; Pagano MA; Nalesso G; Cillo U
Biochim Biophys Acta; 2008 Mar; 1783(3):347-59. PubMed ID: 18157950
[TBL] [Abstract][Full Text] [Related]
9. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
Choi JW; Gardell SE; Herr DR; Rivera R; Lee CW; Noguchi K; Teo ST; Yung YC; Lu M; Kennedy G; Chun J
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):751-6. PubMed ID: 21177428
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
Walter DH; Rochwalsky U; Reinhold J; Seeger F; Aicher A; Urbich C; Spyridopoulos I; Chun J; Brinkmann V; Keul P; Levkau B; Zeiher AM; Dimmeler S; Haendeler J
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):275-82. PubMed ID: 17158356
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of sphingosine 1-phosphate receptor agonist in human endothelial cells.
Butler J; Lana D; Round O; LaMontagne K
Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):29-45. PubMed ID: 15165029
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1-phosphate restrains insulin-mediated keratinocyte proliferation via inhibition of Akt through the S1P2 receptor subtype.
Schüppel M; Kürschner U; Kleuser U; Schäfer-Korting M; Kleuser B
J Invest Dermatol; 2008 Jul; 128(7):1747-56. PubMed ID: 18219276
[TBL] [Abstract][Full Text] [Related]
13. Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis.
Lee CW; Choi JW; Chun J
Arch Pharm Res; 2010 Oct; 33(10):1567-74. PubMed ID: 21052934
[TBL] [Abstract][Full Text] [Related]
14. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720.
Kihara A; Igarashi Y
Biochim Biophys Acta; 2008 Sep; 1781(9):496-502. PubMed ID: 18555808
[TBL] [Abstract][Full Text] [Related]
15. [Effects of sphingosine 1-phosphate on functions of T cell - review].
Huang WR; Wang LS; DA WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):718-22. PubMed ID: 16129068
[TBL] [Abstract][Full Text] [Related]
16. Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors.
Cui QL; Fang J; Kennedy TE; Almazan G; Antel JP
Glia; 2014 Aug; 62(8):1361-75. PubMed ID: 24810969
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer.
Beach JA; Aspuria PJ; Cheon DJ; Lawrenson K; Agadjanian H; Walsh CS; Karlan BY; Orsulic S
Oncotarget; 2016 Jan; 7(4):4167-82. PubMed ID: 26716409
[TBL] [Abstract][Full Text] [Related]
18. Cis-4-methylsphingosine is a sphingosine-1-phosphate receptor modulator.
Ter Braak M; Claas RF; Hegen B; Labocha S; Ferreirós N; Pfeilschifter J; Huwiler A; van Echten-Deckert G; Meyer Zu Heringdorf D
Biochem Pharmacol; 2011 Mar; 81(5):617-25. PubMed ID: 21163254
[TBL] [Abstract][Full Text] [Related]
19. FTY720 Phosphate Activates Sphingosine-1-Phosphate Receptor 2 and Selectively Couples to Gα12/13/Rho/ROCK to Induce Myofibroblast Contraction.
Sobel K; Monnier L; Menyhart K; Bolinger M; Studer R; Nayler O; Gatfield J
Mol Pharmacol; 2015 Jun; 87(6):916-27. PubMed ID: 25762025
[TBL] [Abstract][Full Text] [Related]
20. Non-phosphorylated FTY720 induces apoptosis of human microglia by activating SREBP2.
Yoshino T; Tabunoki H; Sugiyama S; Ishii K; Kim SU; Satoh J
Cell Mol Neurobiol; 2011 Oct; 31(7):1009-20. PubMed ID: 21519925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]